The expected advantage of reducing PTH or calcium levels in the context of hypercalcemia, in combination with mild hyper PTH and low tolerance to oral calcimimetic drugs has to be balanced with complex clinical situations, in which, for example, hypercalcemia is associated with a granulomatous disease. Here, PTH is linked to Hypercalcemia.